MedPath

Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)

Recruiting
Conditions
ALS
Interventions
Other: Observation
Registration Number
NCT03366506
Lead Sponsor
Hadassah Medical Organization
Brief Summary

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

1. Differences between ethnic subgroups

2. Differences between immigrant and native-born populations

3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

Detailed Description

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

1. Differences between ethnic subgroups

2. Differences between immigrant and native-born populations

3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

The clinical features will include pattern of onset, details of full clinical exam ( including ALSFRS-R score, power, reflexes, and other signs of upper or lower-motor neuron dysfunction.

Correlations between different clinical parameters themselves will be made, as well as correlation between clinical parameters and other epidemiological factors.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Suspected, possible, probable ,definite ALS
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ALS patientsObservationALS patients ( suspected, possible, probable or definite per El-Escorial criteria). Observation
Primary Outcome Measures
NameTimeMethod
Progression rateup to 10 years

Progression of ALSFRS-R score over time

Secondary Outcome Measures
NameTimeMethod
Appearance of clinical features of UMN or LMN dysfunction10 years

Appearance of clinical features of UMN or LMN dysfunction over time

Trial Locations

Locations (1)

Hadassah Medical Organisation

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath